Basic Information
| RNALocate ID: | RLID:01001837 |
| RNA Symbol: | hsa-miR-150-5p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-150 |
| RNA ID: | miRBase:MIMAT0000451 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 29784380 |
| Tissue/Cell Line: | Human cervical cancer cell line (HeLa)|Breast cancer cell line (MCF-7) |
| Method: | Confocal laser scanning microscope |
| Description: | The results indicate that miR-150 is localized and distributed in different subcellular organelles (mainly in mitochondria and lysosomes) and that its levels (actually its concentrations) in lysosomes are higher than those in mitochondria in both HeLa and MCF-7 cells. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001836 | Lysosome | HeLa cells|MCF-7 cells | 29784380 |
| RLID:11001921 | Exosome | Peripheral blood | 31746410 |
| RLID:11001922 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11001923 | Exosome | Saliva | 19627513 |
| RLID:11001924 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001925 | Exosome | Breast milk | 22211110 |
| RLID:11001926 | Exosome | Brain tissue | 23382797 |
| RLID:11001927 | Exosome | Plasma | 23663360 |
| RLID:11001928 | Exosome | Serum | 25135963 |
| RLID:11001929 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11001930 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001931 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000099 | Exosome | Blood|B lymphoblastoid cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells | |
| RLID-D:11000379 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-150-5p | Diffuse large b cell lymphoma | MNDR-E-MI-16569 |
| MNDR | hsa-miR-150-5p | Splenic marginal zone lymphoma | MNDR-E-MI-16570 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-16571 |
| MNDR | hsa-miR-150-5p | Large cell neuroendocrine cancer | MNDR-E-MI-16572 |
| MNDR | hsa-miR-150-5p | Medulloblastoma | MNDR-E-MI-16573 |
| MNDR | hsa-miR-150-5p | B cell lymphoma of malt type | MNDR-E-MI-16574 |
| MNDR | hsa-miR-150-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-16575 |
| MNDR | hsa-miR-150-5p | Lymphoma | MNDR-E-MI-16576 |
| MNDR | hsa-miR-150-5p | Lymphoma non-hodgkin | MNDR-E-MI-16577 |
| MNDR | hsa-miR-150-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16578 |
| MNDR | hsa-miR-150-5p | Her2-receptor positive breast cancer | MNDR-E-MI-16579 |
| MNDR | hsa-miR-150-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-16580 |
| MNDR | hsa-miR-150-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-16581 |
| MNDR | hsa-miR-150-5p | Small intestine cancer | MNDR-E-MI-16582 |
| MNDR | hsa-miR-150-5p | Prostate cancer | MNDR-E-MI-16583 |
| MNDR | hsa-miR-150-5p | Chronic lymphocytic leukemia | MNDR-E-MI-16584 |
| MNDR | hsa-miR-150-5p | Gastric cancer | MNDR-E-MI-16585 |
| MNDR | hsa-miR-150-5p | Gastric lymphoma | MNDR-E-MI-16586 |
| MNDR | hsa-miR-150-5p | Alzheimer disease | MNDR-E-MI-16587 |
| MNDR | hsa-miR-150-5p | Intracranial aneurysm | MNDR-E-MI-16588 |
| MNDR | hsa-miR-150-5p | Osteoporosis | MNDR-E-MI-16589 |
| MNDR | hsa-miR-150-5p | Dysautonomia familial | MNDR-E-MI-16590 |
| MNDR | hsa-miR-150-5p | Head and neck cancer | MNDR-E-MI-16591 |
| MNDR | hsa-miR-150-5p | Primary biliary cirrhosis | MNDR-E-MI-16592 |
| MNDR | hsa-miR-150-5p | Leukemia | MNDR-E-MI-16593 |
| MNDR | hsa-miR-150-5p | Huntington disease | MNDR-E-MI-16594 |
| MNDR | hsa-miR-150-5p | Chorea | MNDR-E-MI-16595 |
| MNDR | hsa-miR-150-5p | Cardiovascular disease | MNDR-E-MI-16596 |
| MNDR | hsa-miR-150-5p | Uterine fibroid | MNDR-E-MI-16597 |
| MNDR | hsa-miR-150-5p | Lung cancer | MNDR-E-MI-16598 |
| MNDR | hsa-miR-150-5p | Giant cell arteritis | MNDR-E-MI-16599 |
| MNDR | hsa-miR-150-5p | Kawasaki disease | MNDR-E-MI-16600 |
| MNDR | hsa-miR-150-5p | Down syndrome | MNDR-E-MI-16601 |
| MNDR | hsa-miR-150-5p | Parkinson disease | MNDR-E-MI-16602 |
| MNDR | hsa-miR-150-5p | Basal-like breast cancer | MNDR-E-MI-16603 |
| MNDR | hsa-miR-150-5p | Squamous cell carcinoma | MNDR-E-MI-16604 |
| MNDR | hsa-miR-150-5p | Thyroid cancer | MNDR-E-MI-16605 |
| MNDR | hsa-miR-150-5p | Pituitary neoplasms | MNDR-E-MI-16606 |
| MNDR | hsa-miR-150-5p | Pancreatic cancer | MNDR-E-MI-16607 |
| MNDR | hsa-miR-150-5p | Melanoma | MNDR-E-MI-16608 |
| MNDR | hsa-miR-150-5p | Rectum adenocarcinoma | MNDR-E-MI-16609 |
| MNDR | hsa-miR-150-5p | Nephroblastoma | MNDR-E-MI-16610 |
| MNDR | hsa-miR-150-5p | Colon cancer | MNDR-E-MI-16611 |
| MNDR | hsa-miR-150-5p | Colon adenocarcinoma | MNDR-E-MI-16612 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis | MNDR-E-MI-16613 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-16614 |
| MNDR | hsa-miR-150-5p | Familial ovarian cancer | MNDR-E-MI-16615 |
| MNDR | hsa-miR-150-5p | Kidney cancer | MNDR-E-MI-16616 |
| MNDR | hsa-miR-150-5p | Carcinoma ductal breast | MNDR-E-MI-16617 |
| MNDR | hsa-miR-150-5p | Glioblastoma | MNDR-E-MI-16618 |
| MNDR | hsa-miR-150-5p | Glioma | MNDR-E-MI-16619 |
| MNDR | hsa-miR-150-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-16620 |
| MNDR | hsa-miR-150-5p | Osteosarcoma | MNDR-E-MI-16621 |
| MNDR | hsa-miR-150-5p | Inclusion body myositis | MNDR-E-MI-16622 |
| MNDR | hsa-miR-150-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-16623 |
| MNDR | hsa-miR-150-5p | Liver cancer | MNDR-E-MI-16624 |
| MNDR | hsa-miR-150-5p | Uterine cancer | MNDR-E-MI-16625 |
| MNDR | hsa-miR-150-5p | Gastric adenocarcinoma | MNDR-E-MI-16626 |
| MNDR | hsa-miR-150-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-16627 |
| MNDR | hsa-miR-150-5p | Lung squamous cell carcinoma | MNDR-E-MI-16628 |
| MNDR | hsa-miR-150-5p | Non-small cell lung cancer | MNDR-E-MI-16629 |
| MNDR | hsa-miR-150-5p | Lung adenocarcinoma | MNDR-E-MI-16630 |
| MNDR | hsa-miR-150-5p | Adrenocortical carcinoma | MNDR-E-MI-16631 |
| MNDR | hsa-miR-150-5p | Thyroid carcinoma | MNDR-E-MI-16632 |
| MNDR | hsa-miR-150-5p | Papillary thyroid carcinoma | MNDR-E-MI-16633 |
| MNDR | hsa-miR-150-5p | Bladder urothelial carcinoma | MNDR-E-MI-16634 |
| MNDR | hsa-miR-150-5p | Pancreatic adenocarcinoma | MNDR-E-MI-16635 |
| MNDR | hsa-miR-150-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-16636 |
| MNDR | hsa-miR-150-5p | Carcinoma renal cell | MNDR-E-MI-16637 |
| MNDR | hsa-miR-150-5p | Papillary renal cell carcinoma | MNDR-E-MI-16638 |
| MNDR | hsa-miR-150-5p | Renal clear cell carcinoma | MNDR-E-MI-16639 |
| MNDR | hsa-miR-150-5p | Biliary tract cancer | MNDR-E-MI-16640 |
| MNDR | hsa-miR-150-5p | Cholangiocarcinoma | MNDR-E-MI-16641 |
| MNDR | hsa-miR-150-5p | Pancreatitis | MNDR-E-MI-16642 |
| MNDR | hsa-miR-150-5p | Esophageal cancer | MNDR-E-MI-16643 |
| MNDR | hsa-miR-150-5p | HIV | MNDR-E-MI-16644 |
| MNDR | hsa-miR-150-5p | Lung small cell carcinoma | MNDR-E-MI-16645 |
| MNDR | hsa-miR-150-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-16646 |
| MNDR | hsa-miR-150-5p | Testicular germ cell cancer | MNDR-E-MI-16647 |
| MNDR | hsa-miR-150-5p | T acute lymphoblastic leukemia | MNDR-E-MI-16648 |
| MNDR | hsa-miR-150-5p | Acute t cell leukemia | MNDR-E-MI-16649 |
| MNDR | hsa-miR-150-5p | Heart failure | MNDR-E-MI-16650 |
| MNDR | hsa-miR-150-5p | Adenoma | MNDR-E-MI-16651 |
| MNDR | hsa-miR-150-5p | Breast invasive carcinoma | MNDR-E-MI-16652 |
| MNDR | hsa-miR-150-5p | Early hepatocellular carcinoma | MNDR-E-MI-16653 |
| MNDR | hsa-miR-150-5p | Familiar ovarian carcinoma | MNDR-E-MI-16654 |
| MNDR | hsa-miR-150-5p | B-cell lymphoma | MNDR-E-MI-16655 |
| MNDR | hsa-miR-150-5p | Rheumatoid arthritis | MNDR-E-MI-16656 |
| MNDR | hsa-miR-150-5p | T-cell leukemia | MNDR-E-MI-16657 |
| MNDR | hsa-miR-150-5p | Retinoblastoma | MNDR-E-MI-16658 |
| MNDR | hsa-miR-150-5p | Neuroblastoma | MNDR-E-MI-16659 |
| MNDR | hsa-miR-150-5p | Periodontitis | MNDR-E-MI-16660 |
| MNDR | hsa-miR-150-5p | Hodgkin lymphoma | MNDR-E-MI-16661 |
| MNDR | hsa-miR-150-5p | Burkitt lymphoma | MNDR-E-MI-16662 |
| MNDR | hsa-miR-150-5p | Skin cutaneous melanoma | MNDR-E-MI-16663 |
| MNDR | hsa-miR-150-5p | Skin melanoma | MNDR-E-MI-16664 |
| MNDR | hsa-miR-150-5p | Systemic lupus erythematosus | MNDR-E-MI-16665 |
| MNDR | hsa-miR-150-5p | Acute myelogenous leukemia | MNDR-E-MI-16666 |
| MNDR | hsa-miR-150-5p | Colorectal cancer | MNDR-E-MI-16667 |
| MNDR | hsa-miR-150-5p | Nasopharynx carcinoma | MNDR-E-MI-16668 |
| MNDR | hsa-miR-150-5p | Acute myocardial infarction | MNDR-E-MI-16669 |
| MNDR | hsa-miR-150-5p | Multiple myeloma | MNDR-E-MI-16670 |
| MNDR | hsa-miR-150-5p | Ovarian epithelial cancer | MNDR-E-MI-16671 |
| MNDR | hsa-miR-150-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-16672 |
| MNDR | hsa-miR-150-5p | Ependymoma | MNDR-E-MI-16673 |
| MNDR | hsa-miR-150-5p | Cardiomegaly | MNDR-E-MI-16674 |
| MNDR | hsa-miR-150-5p | Infection | MNDR-E-MI-16675 |
| MNDR | hsa-miR-150-5p | Nasopharyngeal cancer | MNDR-E-MI-16676 |
| MNDR | hsa-miR-150-5p | Sleep deprivation | MNDR-E-MI-16677 |
| MNDR | hsa-miR-150-5p | Wounds and injuries | MNDR-E-MI-16678 |
| MNDR | hsa-miR-150-5p | Epstein-barr virus infections | MNDR-E-MI-16679 |
| MNDR | hsa-miR-150-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16680 |
| MNDR | hsa-miR-150-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-16681 |
| MNDR | hsa-miR-150-5p | Pituitary acth hypersecretion | MNDR-E-MI-16682 |
| MNDR | hsa-miR-150-5p | Stroke lacunar | MNDR-E-MI-16683 |
| MNDR | hsa-miR-150-5p | Duke A | MNDR-E-MI-16684 |
| MNDR | hsa-miR-150-5p | Tubulovillous adenoma | MNDR-E-MI-16685 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADIPOR2 | Homo sapiens | RR00047795 |
TOP